「calibration」の検索結果

Onboard a new model generation or sibling into oh-my-hermes: probe router recognition, research the official contract, write trait-to-counter calibration, place routing in both lanes, price from documented list only, gate machine config on a served route, prove with the gates, close with a benchmark pair. Use when a model family ships a new generation (for example "Fable 5.1 is out", "GLM 5.4 shipped", "onboard new model", "add model to chains").

日本語の概要は準備中です。原文の説明を表示しています。

Targeted metabolomics analysis using MRM/SRM with standard curves. Covers absolute quantification, method validation, and quality assessment. Use when quantifying specific metabolites using calibration curves and internal standards.

日本語の概要は準備中です。原文の説明を表示しています。

Variant calling with GATK HaplotypeCaller following best practices. Covers germline SNP/indel calling, GVCF workflow for cohorts, joint genotyping, and variant quality score recalibration (VQSR). Use when calling variants with GATK HaplotypeCaller.

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "plan my launch tier", "how big should this launch be", or "build a launch risk register with kill criteria"; produces a tier decision (Tier 1 flagship all-channel / Tier 2 targeted / Tier 3 changelog-level), a launch-type declaration (new-product / feature / relaunch / partnership with co-marketing split), an effort calibration matrix (tier to channel intensity and asset scope), D0/W1/M1 KPI targets (labeled Estimated), a risk register (likelihood x blast-radius, owners, mitigations, kill criteria / rollback thresholds), and a T-8w to T+4w timeline skeleton. Not for picking the launch date or window — use launch-window-planner; not for creator-channel launch campaigns — use campaign-planner. 发布分级/发布类型/风险登记册/kill criteria

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete conventional non-oncology diagnostic machine-learning research designs from a user-provided disease context, optional mechanism theme, and validation direction. Use when a study centers on disease-vs-control transcriptome comparison, optional mechanism-gene restriction, feature shrinkage, diagnostic model construction, ROC / calibration / DCA evaluation, interpretation layers, and orthogonal validation. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Use when constructing a prognosis nomogram from survival-related clinical predictors, exporting the nomogram bundle and C-index table, and optionally rendering the final nomogram PDF. NOT for: univariate/multivariable Cox feature screening, calibration curves, ROC analysis, decision-curve analysis, or non-survival outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Use when evaluating diagnostic biomarker performance from case-control expression data with logistic regression and ROC curves, exporting coefficient and AUC tables together with a ROC PDF. NOT for: survival analysis, time-to-event outcomes, multiclass classification, calibration curves, decision-curve analysis, or nomogram construction.

日本語の概要は準備中です。原文の説明を表示しています。

Use when running prognostic survival analysis on a clinical cohort with time-to-event data to estimate univariate and multivariable Cox proportional hazards models, export result tables, and generate forest plots. NOT for: nomogram construction, calibration curves, time-dependent ROC analysis, or model training/feature selection beyond the built-in univariate screening rule.

日本語の概要は準備中です。原文の説明を表示しています。

Use when evaluating the clinical utility of a binary prediction model from a single clinical CSV file by fitting a logistic decision-curve model, plotting decision and clinical-impact curves, and exporting summary outputs. NOT for: survival calibration, ROC-only discrimination analysis, nomogram construction, or time-to-event outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Use when validating an existing prognostic risk signature on an external bulk expression cohort with survival outcomes, producing risk scores, Kaplan-Meier curves, risk distribution plots, heatmap, and time-dependent ROC curves. NOT for: model training, feature selection, nomogram construction, calibration analysis, or single-cell data.

日本語の概要は準備中です。原文の説明を表示しています。

This skill should be considered when you need to normalize testing engineers' written defect reasons following the provided product codebooks. This skill will correct the typos, misused abbreviations, ambiguous descriptions, mixed Chinese-English text or misleading text and provide explanations. This skill will do segmentation, semantic matching, confidence calibration and station validation.

日本語の概要は準備中です。原文の説明を表示しています。

Calibrate GLM parameters for water temperature simulation. Use when you need to adjust model parameters to minimize RMSE between simulated and observed temperatures.

日本語の概要は準備中です。原文の説明を表示しています。

Generates several distinct, clickable HTML interaction prototypes for one product surface into a Design Board and collects selection/remix feedback before implementation. Use for multiple UI versions, interaction alternatives, progressive-disclosure options, or when styling is fine but hierarchy/workflow/interaction feels off. Not for static visual-style calibration (use design-style-picker) or a settled CSS tweak.

日本語の概要は準備中です。原文の説明を表示しています。

Evaluate performance fairly when output is AI-assisted — what still measures the human, what now measures the tooling, and how to run the review conversation. Use when reviewing someone whose work is heavily AI-assisted, when output volume stopped meaning anything, when calibrating a team with uneven AI adoption, or when writing review criteria for the AI era. Produces review guidance: a what-measures-whom analysis, rewritten criteria, calibration rules for mixed-adoption teams, and conversation scripts. For the general review document use performance-review; for redesigning the role itself use role-redesign-for-ai.

日本語の概要は準備中です。原文の説明を表示しています。

Inspect an agent repository and optional traces, interview the user, write reviewed Task Specs, build and audit Harbor tasks, and bootstrap reusable project World Knowledge Skills. Use for agent evals, benchmark design, Task generation, controlled Environments, synthetic data, Verifiers, Harbor runs, calibration, or continuous benchmark maintenance.

日本語の概要は準備中です。原文の説明を表示しています。

Use when the quantitative model is the bottleneck for an American Economic Journal: Macroeconomics (AEJ: Macro) manuscript — DSGE, New Keynesian, heterogeneous-agent (HANK / Aiyagari-Bewley), or structural estimation — and calibration, parameter identification, solution accuracy, or counterfactual validity need discipline. For empirical shock identification see aejmac-identification.

日本語の概要は準備中です。原文の説明を表示しています。

Use when assembling the data, code, and documentation package for an American Economic Journal: Macroeconomics (AEJ: Macro) manuscript to pass the AEA Data and Code Availability Policy and the AEA Data Editor's pre-publication reproducibility check. Covers macro specifics (simulation/calibration code, restricted-access data); it does not write the analysis itself.

日本語の概要は準備中です。原文の説明を表示しています。

Lead qualification engine with conversational intake. Asks structured questions to understand your qualification criteria, generates a reusable qualification prompt, then batch-enriches leads via Apify LinkedIn scraping and scores them with parallel processing. Outputs qualified/disqualified verdicts with confidence scores and reasoning to CSV or whatever output format the user prefers. Supports calibration mode for prompt refinement.

日本語の概要は準備中です。原文の説明を表示しています。

Processes eDNA metabarcoding from raw paired-end reads to species tables, navigating ASV (DADA2, UNOISE3) vs OTU (swarm v2) decision (Callahan 2017 vs Schloss multi-copy-16S critique), marker/primer choice (Leray COI, MiFish 12S, 515F/806R 16S, ITS2) with primer-specific bias, OBITools3 v3 command-name break (obi stats plural; .tar.gz taxonomy), tag-jumping with dual-indexing (Schnell 2015; NovaSeq 10x MiSeq), decontam as screening-not-classifier (Davis 2018), read-counts-not-abundance critique (Lamb 2019), site-occupancy modeling (Ficetola 2015), Naive-Bayes calibration limits (Bokulich 2018), and eDNA decay (Strickler 2015). Use when going from raw eDNA FASTQ to species tables, picking marker + denoising pipeline, deciding whether read counts represent abundance, applying occupancy modeling, configuring OBITools3 v3, or interpreting decontam output. Not for clinical 16S microbiome (see microbiome/amplicon-processing).

日本語の概要は準備中です。原文の説明を表示しています。

Delimits putative species boundaries from molecular data within the de Queiroz 2007 unified-lineage framework using ASAP (Puillandre 2021 successor to ABGD), mPTP C++ (Kapli 2017 successor to bPTP; bPTP is Python NOT R), GMYC single/multi-threshold (Pons 2006; Fujisawa 2013), multilocus BPP v4 with prior calibration from data (NOT defaults; Yang 2015), SNAPP + BFD* for SNP delimitation, DELINEATE (Sukumaran 2021) speciation-process modeling to address Sukumaran & Knowles 2017 PNAS critique that MSC delimits structure not species, integrative-taxonomy congruence (Padial 2010; Carstens 2013), Dsuite for introgression testing before sister claims (Malinsky 2021), and Meyer & Paulay 2005 barcoding-gap-absence caveat. Use when delineating species from DNA barcoding data, resolving cryptic complexes, choosing among ASAP/mPTP/BPP/DELINEATE, calibrating BPP priors, distinguishing introgression from ILS, or applying the Sukumaran-Knowles oversplitting correction.

日本語の概要は準備中です。原文の説明を表示しています。

Quality control for flow, spectral, and mass cytometry - time-based anomaly cleaning (flowAI, flowCut, PeacoQC, flowClean), margin/boundary event removal, signal-drift detection, dead-cell exclusion, CyTOF Gaussian/DNA/event-length checks, instrument calibration/standardization (MESF, CS&T, peak-2), and batch-level outlier flagging. Use when assessing acquisition quality, choosing a cleaning tool, ordering QC relative to compensation, deciding margin removal before density-based steps, or flagging problematic samples before clustering or differential analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Constructs and validates polygenic risk scores using LDpred2-auto, SBayesRC, MegaPRS, PRS-CS, PROSPER, MUSSEL, BridgePRS, JointPRS, PRSmix, or PGS Catalog Calculator with ancestry-aware reference panels (HapMap3, UKB-LD), ancestry-conditional calibration, and PRS-RS reporting standards. Use when computing PRS for cohorts, applying absolute-risk transformation, assessing cross-ancestry portability (Martin 2017 / Ding 2023 continuous ancestry), or auditing PRS manuscripts against the 22-item PRS-RS reviewer checklist.

日本語の概要は準備中です。原文の説明を表示しています。

Map N6-methyladenosine (m6A) RNA modifications at single-nucleotide resolution using miCLIP (Linder 2015), miCLIP2 + m6Aboost machine learning (Kortel 2021), GLORI (Liu 2023, antibody-free chemical conversion), DART-seq (Meyer 2019, APOBEC1-YTH fusion), m6Anet (nanopore direct RNA), or MeRIP-seq with calibration. Use when distinguishing antibody-based from antibody-free m6A detection methods, applying the DRACH motif constraint, reconciling cross-method disagreements (DART 44% in DRACH vs GLORI), or detecting m6Am at the cap.

日本語の概要は準備中です。原文の説明を表示しています。

Prioritizes rare-disease variants from trio/quad WES/WGS with de novo (DeNovoGear, Triodenovo), compound-heterozygous phasing (WhatsHap), mosaic VAF tiering, phenotype-driven ranking (Exomiser, Phen2Gene, AMELIE), ClinGen gene-disease validity gating, and ACMG SF v3.2 secondary findings reporting. Use when running diagnostic exome / genome pipelines, identifying candidate Mendelian disease genes, screening for incidental findings, or auditing VUS reclassification cycles. The ACMG/AMP classification framework (PVS1 decision tree, Pejaver PP3/BP4 calibration, Tavtigian point system) is in clinical-databases/acmg-classification.

日本語の概要は準備中です。原文の説明を表示しています。